LianBio Hires Cross-Border Industry Veteran as CEO

LianBio, a Shanghai-Princeton biotech, announced Yizhe Wang, PhD, will become the company's CEO and a member of the Board of Directors. Dr. Wang has worked for Eli Lilly and GlaxoSmithKline, leading drug development and commercial launches in China and the US . In a telephone interview, Debra Yu, MD, LianBio President and Chief Business Officer, told ChinaBio Today , "As a company, we're thrilled about Yizhe joining us. It is rare to find somebody with solid executional leadership experience in development and commercialization in the US and China . He is strategic and passionate with a long track record of leading cross-border teams. He's very dynamic with an ability to talk to our partners and key opinion leaders. He will be a good fit for LianBio." More details.... Share this with colleagues: // //
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.